Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04854096
Title Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NS Pharma, Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | DEU

No variant requirements are available.